
Global Opioid Analgesics Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Opioid Analgesics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Opioid Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Opioid Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Opioid Analgesics market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Opioid Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Opioid Analgesics market include Assertio Holdings, Inc, Bausch Health, Boehringer Ingelheim International GmbH, Endo International Plc, F. Hoffmann-La Roche AG, Purdue Pharmaceuticals L.P., Sanofi S.A., Teva Pharmaceuticals and Abbott Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Opioid Analgesics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Opioid Analgesics, also provides the sales of main regions and countries. Of the upcoming market potential for Opioid Analgesics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Opioid Analgesics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Opioid Analgesics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Opioid Analgesics sales, projected growth trends, production technology, application and end-user industry.
Opioid Analgesics Segment by Company
Assertio Holdings, Inc
Bausch Health
Boehringer Ingelheim International GmbH
Endo International Plc
F. Hoffmann-La Roche AG
Purdue Pharmaceuticals L.P.
Sanofi S.A.
Teva Pharmaceuticals
Abbott Laboratories
Bayer AG
GlaxoSmithKline plc
Pfizer Inc.
Novartis AG
Johnson & Johnson
Opioid Analgesics Segment by Type
Morphine
Methadone
OxyContin
Vicodin
Others
Opioid Analgesics Segment by Application
Surgical Pain
Neuropathic Pain
Cancer Pain
Others
Opioid Analgesics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Opioid Analgesics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Opioid Analgesics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Opioid Analgesics significant trends, drivers, influence factors in global and regions.
6. To analyze Opioid Analgesics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioid Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Analgesics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Opioid Analgesics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Opioid Analgesics industry.
Chapter 3: Detailed analysis of Opioid Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Opioid Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Opioid Analgesics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
According to APO Research, the global Opioid Analgesics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Opioid Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Opioid Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Opioid Analgesics market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Opioid Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Opioid Analgesics market include Assertio Holdings, Inc, Bausch Health, Boehringer Ingelheim International GmbH, Endo International Plc, F. Hoffmann-La Roche AG, Purdue Pharmaceuticals L.P., Sanofi S.A., Teva Pharmaceuticals and Abbott Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Opioid Analgesics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Opioid Analgesics, also provides the sales of main regions and countries. Of the upcoming market potential for Opioid Analgesics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Opioid Analgesics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Opioid Analgesics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Opioid Analgesics sales, projected growth trends, production technology, application and end-user industry.
Opioid Analgesics Segment by Company
Assertio Holdings, Inc
Bausch Health
Boehringer Ingelheim International GmbH
Endo International Plc
F. Hoffmann-La Roche AG
Purdue Pharmaceuticals L.P.
Sanofi S.A.
Teva Pharmaceuticals
Abbott Laboratories
Bayer AG
GlaxoSmithKline plc
Pfizer Inc.
Novartis AG
Johnson & Johnson
Opioid Analgesics Segment by Type
Morphine
Methadone
OxyContin
Vicodin
Others
Opioid Analgesics Segment by Application
Surgical Pain
Neuropathic Pain
Cancer Pain
Others
Opioid Analgesics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Opioid Analgesics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Opioid Analgesics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Opioid Analgesics significant trends, drivers, influence factors in global and regions.
6. To analyze Opioid Analgesics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioid Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Analgesics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Opioid Analgesics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Opioid Analgesics industry.
Chapter 3: Detailed analysis of Opioid Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Opioid Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Opioid Analgesics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Table of Contents
194 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Opioid Analgesics Sales Value (2020-2031)
- 1.2.2 Global Opioid Analgesics Sales Volume (2020-2031)
- 1.2.3 Global Opioid Analgesics Sales Average Price (2020-2031)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
- 2 Opioid Analgesics Market Dynamics
- 2.1 Opioid Analgesics Industry Trends
- 2.2 Opioid Analgesics Industry Drivers
- 2.3 Opioid Analgesics Industry Opportunities and Challenges
- 2.4 Opioid Analgesics Industry Restraints
- 3 Opioid Analgesics Market by Company
- 3.1 Global Opioid Analgesics Company Revenue Ranking in 2024
- 3.2 Global Opioid Analgesics Revenue by Company (2020-2025)
- 3.3 Global Opioid Analgesics Sales Volume by Company (2020-2025)
- 3.4 Global Opioid Analgesics Average Price by Company (2020-2025)
- 3.5 Global Opioid Analgesics Company Ranking (2023-2025)
- 3.6 Global Opioid Analgesics Company Manufacturing Base and Headquarters
- 3.7 Global Opioid Analgesics Company Product Type and Application
- 3.8 Global Opioid Analgesics Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Opioid Analgesics Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.9.3 2024 Opioid Analgesics Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
- 4 Opioid Analgesics Market by Type
- 4.1 Opioid Analgesics Type Introduction
- 4.1.1 Morphine
- 4.1.2 Methadone
- 4.1.3 OxyContin
- 4.1.4 Vicodin
- 4.1.5 Others
- 4.2 Global Opioid Analgesics Sales Volume by Type
- 4.2.1 Global Opioid Analgesics Sales Volume by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Opioid Analgesics Sales Volume by Type (2020-2031)
- 4.2.3 Global Opioid Analgesics Sales Volume Share by Type (2020-2031)
- 4.3 Global Opioid Analgesics Sales Value by Type
- 4.3.1 Global Opioid Analgesics Sales Value by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Opioid Analgesics Sales Value by Type (2020-2031)
- 4.3.3 Global Opioid Analgesics Sales Value Share by Type (2020-2031)
- 5 Opioid Analgesics Market by Application
- 5.1 Opioid Analgesics Application Introduction
- 5.1.1 Surgical Pain
- 5.1.2 Neuropathic Pain
- 5.1.3 Cancer Pain
- 5.1.4 Others
- 5.2 Global Opioid Analgesics Sales Volume by Application
- 5.2.1 Global Opioid Analgesics Sales Volume by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Opioid Analgesics Sales Volume by Application (2020-2031)
- 5.2.3 Global Opioid Analgesics Sales Volume Share by Application (2020-2031)
- 5.3 Global Opioid Analgesics Sales Value by Application
- 5.3.1 Global Opioid Analgesics Sales Value by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Opioid Analgesics Sales Value by Application (2020-2031)
- 5.3.3 Global Opioid Analgesics Sales Value Share by Application (2020-2031)
- 6 Opioid Analgesics Regional Sales and Value Analysis
- 6.1 Global Opioid Analgesics Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Opioid Analgesics Sales by Region (2020-2031)
- 6.2.1 Global Opioid Analgesics Sales by Region: 2020-2025
- 6.2.2 Global Opioid Analgesics Sales by Region (2026-2031)
- 6.3 Global Opioid Analgesics Sales Value by Region: 2020 VS 2024 VS 2031
- 6.4 Global Opioid Analgesics Sales Value by Region (2020-2031)
- 6.4.1 Global Opioid Analgesics Sales Value by Region: 2020-2025
- 6.4.2 Global Opioid Analgesics Sales Value by Region (2026-2031)
- 6.5 Global Opioid Analgesics Market Price Analysis by Region (2020-2025)
- 6.6 North America
- 6.6.1 North America Opioid Analgesics Sales Value (2020-2031)
- 6.6.2 North America Opioid Analgesics Sales Value Share by Country, 2024 VS 2031
- 6.7 Europe
- 6.7.1 Europe Opioid Analgesics Sales Value (2020-2031)
- 6.7.2 Europe Opioid Analgesics Sales Value Share by Country, 2024 VS 2031
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Opioid Analgesics Sales Value (2020-2031)
- 6.8.2 Asia-Pacific Opioid Analgesics Sales Value Share by Country, 2024 VS 2031
- 6.9 South America
- 6.9.1 South America Opioid Analgesics Sales Value (2020-2031)
- 6.9.2 South America Opioid Analgesics Sales Value Share by Country, 2024 VS 2031
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Opioid Analgesics Sales Value (2020-2031)
- 6.10.2 Middle East & Africa Opioid Analgesics Sales Value Share by Country, 2024 VS 2031
- 7 Opioid Analgesics Country-level Sales and Value Analysis
- 7.1 Global Opioid Analgesics Sales by Country: 2020 VS 2024 VS 2031
- 7.2 Global Opioid Analgesics Sales Value by Country: 2020 VS 2024 VS 2031
- 7.3 Global Opioid Analgesics Sales by Country (2020-2031)
- 7.3.1 Global Opioid Analgesics Sales by Country (2020-2025)
- 7.3.2 Global Opioid Analgesics Sales by Country (2026-2031)
- 7.4 Global Opioid Analgesics Sales Value by Country (2020-2031)
- 7.4.1 Global Opioid Analgesics Sales Value by Country (2020-2025)
- 7.4.2 Global Opioid Analgesics Sales Value by Country (2026-2031)
- 7.5 USA
- 7.5.1 USA Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.5.2 USA Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.5.3 USA Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.6 Canada
- 7.6.1 Canada Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.6.2 Canada Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Canada Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.7 Mexico
- 7.6.1 Mexico Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.6.2 Mexico Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Mexico Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.8 Germany
- 7.8.1 Germany Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.8.2 Germany Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.8.3 Germany Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.9 France
- 7.9.1 France Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.9.2 France Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.9.3 France Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.10 U.K.
- 7.10.1 U.K. Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.10.2 U.K. Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.10.3 U.K. Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.11 Italy
- 7.11.1 Italy Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.11.2 Italy Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Italy Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.12 Spain
- 7.12.1 Spain Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.12.2 Spain Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Spain Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.13 Russia
- 7.13.1 Russia Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.13.2 Russia Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Russia Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.14 Netherlands
- 7.14.1 Netherlands Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.14.2 Netherlands Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.14.3 Netherlands Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.15.2 Nordic Countries Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Nordic Countries Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.16 China
- 7.16.1 China Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.16.2 China Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.16.3 China Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.17 Japan
- 7.17.1 Japan Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.17.2 Japan Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.17.3 Japan Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.18 South Korea
- 7.18.1 South Korea Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.18.2 South Korea Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.18.3 South Korea Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.19 India
- 7.19.1 India Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.19.2 India Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.19.3 India Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.20 Australia
- 7.20.1 Australia Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.20.2 Australia Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Australia Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.21.2 Southeast Asia Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Southeast Asia Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.22 Brazil
- 7.22.1 Brazil Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.22.2 Brazil Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Brazil Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.23 Argentina
- 7.23.1 Argentina Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.23.2 Argentina Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Argentina Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.24 Chile
- 7.24.1 Chile Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.24.2 Chile Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Chile Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.25 Colombia
- 7.25.1 Colombia Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.25.2 Colombia Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Colombia Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.26 Peru
- 7.26.1 Peru Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.26.2 Peru Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Peru Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.27.2 Saudi Arabia Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.27.3 Saudi Arabia Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.28 Israel
- 7.28.1 Israel Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.28.2 Israel Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Israel Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.29 UAE
- 7.29.1 UAE Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.29.2 UAE Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.29.3 UAE Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.30 Turkey
- 7.30.1 Turkey Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.30.2 Turkey Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Turkey Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.31 Iran
- 7.31.1 Iran Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.31.2 Iran Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.31.3 Iran Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 7.32 Egypt
- 7.32.1 Egypt Opioid Analgesics Sales Value Growth Rate (2020-2031)
- 7.32.2 Egypt Opioid Analgesics Sales Value Share by Type, 2024 VS 2031
- 7.32.3 Egypt Opioid Analgesics Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Assertio Holdings, Inc
- 8.1.1 Assertio Holdings, Inc Comapny Information
- 8.1.2 Assertio Holdings, Inc Business Overview
- 8.1.3 Assertio Holdings, Inc Opioid Analgesics Sales, Value and Gross Margin (2020-2025)
- 8.1.4 Assertio Holdings, Inc Opioid Analgesics Product Portfolio
- 8.1.5 Assertio Holdings, Inc Recent Developments
- 8.2 Bausch Health
- 8.2.1 Bausch Health Comapny Information
- 8.2.2 Bausch Health Business Overview
- 8.2.3 Bausch Health Opioid Analgesics Sales, Value and Gross Margin (2020-2025)
- 8.2.4 Bausch Health Opioid Analgesics Product Portfolio
- 8.2.5 Bausch Health Recent Developments
- 8.3 Boehringer Ingelheim International GmbH
- 8.3.1 Boehringer Ingelheim International GmbH Comapny Information
- 8.3.2 Boehringer Ingelheim International GmbH Business Overview
- 8.3.3 Boehringer Ingelheim International GmbH Opioid Analgesics Sales, Value and Gross Margin (2020-2025)
- 8.3.4 Boehringer Ingelheim International GmbH Opioid Analgesics Product Portfolio
- 8.3.5 Boehringer Ingelheim International GmbH Recent Developments
- 8.4 Endo International Plc
- 8.4.1 Endo International Plc Comapny Information
- 8.4.2 Endo International Plc Business Overview
- 8.4.3 Endo International Plc Opioid Analgesics Sales, Value and Gross Margin (2020-2025)
- 8.4.4 Endo International Plc Opioid Analgesics Product Portfolio
- 8.4.5 Endo International Plc Recent Developments
- 8.5 F. Hoffmann-La Roche AG
- 8.5.1 F. Hoffmann-La Roche AG Comapny Information
- 8.5.2 F. Hoffmann-La Roche AG Business Overview
- 8.5.3 F. Hoffmann-La Roche AG Opioid Analgesics Sales, Value and Gross Margin (2020-2025)
- 8.5.4 F. Hoffmann-La Roche AG Opioid Analgesics Product Portfolio
- 8.5.5 F. Hoffmann-La Roche AG Recent Developments
- 8.6 Purdue Pharmaceuticals L.P.
- 8.6.1 Purdue Pharmaceuticals L.P. Comapny Information
- 8.6.2 Purdue Pharmaceuticals L.P. Business Overview
- 8.6.3 Purdue Pharmaceuticals L.P. Opioid Analgesics Sales, Value and Gross Margin (2020-2025)
- 8.6.4 Purdue Pharmaceuticals L.P. Opioid Analgesics Product Portfolio
- 8.6.5 Purdue Pharmaceuticals L.P. Recent Developments
- 8.7 Sanofi S.A.
- 8.7.1 Sanofi S.A. Comapny Information
- 8.7.2 Sanofi S.A. Business Overview
- 8.7.3 Sanofi S.A. Opioid Analgesics Sales, Value and Gross Margin (2020-2025)
- 8.7.4 Sanofi S.A. Opioid Analgesics Product Portfolio
- 8.7.5 Sanofi S.A. Recent Developments
- 8.8 Teva Pharmaceuticals
- 8.8.1 Teva Pharmaceuticals Comapny Information
- 8.8.2 Teva Pharmaceuticals Business Overview
- 8.8.3 Teva Pharmaceuticals Opioid Analgesics Sales, Value and Gross Margin (2020-2025)
- 8.8.4 Teva Pharmaceuticals Opioid Analgesics Product Portfolio
- 8.8.5 Teva Pharmaceuticals Recent Developments
- 8.9 Abbott Laboratories
- 8.9.1 Abbott Laboratories Comapny Information
- 8.9.2 Abbott Laboratories Business Overview
- 8.9.3 Abbott Laboratories Opioid Analgesics Sales, Value and Gross Margin (2020-2025)
- 8.9.4 Abbott Laboratories Opioid Analgesics Product Portfolio
- 8.9.5 Abbott Laboratories Recent Developments
- 8.10 Bayer AG
- 8.10.1 Bayer AG Comapny Information
- 8.10.2 Bayer AG Business Overview
- 8.10.3 Bayer AG Opioid Analgesics Sales, Value and Gross Margin (2020-2025)
- 8.10.4 Bayer AG Opioid Analgesics Product Portfolio
- 8.10.5 Bayer AG Recent Developments
- 8.11 GlaxoSmithKline plc
- 8.11.1 GlaxoSmithKline plc Comapny Information
- 8.11.2 GlaxoSmithKline plc Business Overview
- 8.11.3 GlaxoSmithKline plc Opioid Analgesics Sales, Value and Gross Margin (2020-2025)
- 8.11.4 GlaxoSmithKline plc Opioid Analgesics Product Portfolio
- 8.11.5 GlaxoSmithKline plc Recent Developments
- 8.12 Pfizer Inc.
- 8.12.1 Pfizer Inc. Comapny Information
- 8.12.2 Pfizer Inc. Business Overview
- 8.12.3 Pfizer Inc. Opioid Analgesics Sales, Value and Gross Margin (2020-2025)
- 8.12.4 Pfizer Inc. Opioid Analgesics Product Portfolio
- 8.12.5 Pfizer Inc. Recent Developments
- 8.13 Novartis AG
- 8.13.1 Novartis AG Comapny Information
- 8.13.2 Novartis AG Business Overview
- 8.13.3 Novartis AG Opioid Analgesics Sales, Value and Gross Margin (2020-2025)
- 8.13.4 Novartis AG Opioid Analgesics Product Portfolio
- 8.13.5 Novartis AG Recent Developments
- 8.14 Johnson & Johnson
- 8.14.1 Johnson & Johnson Comapny Information
- 8.14.2 Johnson & Johnson Business Overview
- 8.14.3 Johnson & Johnson Opioid Analgesics Sales, Value and Gross Margin (2020-2025)
- 8.14.4 Johnson & Johnson Opioid Analgesics Product Portfolio
- 8.14.5 Johnson & Johnson Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Opioid Analgesics Value Chain Analysis
- 9.1.1 Opioid Analgesics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Opioid Analgesics Sales Mode & Process
- 9.2 Opioid Analgesics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Opioid Analgesics Distributors
- 9.2.3 Opioid Analgesics Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.